Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects
elderly individuals. Increase in incidence rates in the past decades has been attributed to …

Bullous pemphigoid (BP) is an organ-specific autoantibody-mediated blistering skin disease
that mainly affects the elderly. Typical clinical features include the widespread blisters, often …

Many ulcerative or vesiculobullous disease of the mouth have a similar clinical appearance.
The oral mucosa is thin, and even slight trauma leads to rupture of vesicles and bullae …

Background A rising incidence and high mortality were found for bullous pemphigoid (BP)
over a decade ago in the UK. Updated estimates of its epidemiology are required to …

Routine systemic therapy for bullous pemphigoid (BP) has been challenged due to the
inevitably adverse effects. According to the successful applications of dupilumab in BP …

The risk of developing psoriasis during the course of bullous pemphigoid (BP) is yet to be
investigated. We aimed to assess the risk of psoriasis among patients with BP and the risk of …

Importance The role of bullous pemphigoid (BP) in cardiovascular disease (CVD) mortality
remains controversial, and analyses of causes of death among patients with BP based on …

Background Interest in the use of omalizumab to treat bullous pemphigoid (BP) in the event
of resistance or contraindication to conventional therapies is currently based on limited …

Importance The 1-year standardized mortality ratio (SMR) of bullous pemphigoid (BP) has
been reported as 2.15 to 7.56 and lower in the US than in Europe. Objective To estimate the …

Bullous pemphigoid is a subepidermal blistering disease associated with autoantibodies
(auto-ab) to BP180 and BP230 which affects elderly patients, predominately. Although it is a …